General Catalyst

Activity from announced rounds

Activity in this selectionOct 11, 2026 · Europe · Jul 14, 2026

General Catalyst backs companies from formation and seed through growth, and also creates businesses with founders through its Creation strategy.

Creation includes starting companies in complex or emerging industries, helping experienced founders launch again and combining existing service businesses with applied AI. That makes GC relevant both to founders raising for an established startup and to entrepreneurs developing a new company with an investment partner.

For businesses that have reached product-market fit, its Customer Value Fund provides a separate way to finance customer acquisition. This sits alongside seed and growth equity, giving the firm a financing model directed specifically at the cost of expanding a customer base.

Sources
Rounds participated in
5
Confirmed lead rounds
1
3 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$746M
5 disclosed · full round size, not this investor’s share

By stage

Seed3
Series A1
Series C+1

By primary sector

Developer tools1
Enterprise software1
Fintech1
Healthtech1
Logistics1

By country

Sweden2
Denmark1
Germany1
United Kingdom1

Rounds

5 in this selection
Complir

Complir helps retailers and brands manage product safety and regulatory compliance across the markets where they sell.

$11MSeed
Lead
Integral

Integral combines AI-assisted accounting, tax and payroll operations with licensed professionals for small and mid-sized businesses in Germany. Its platform connects bank transactions, receipts, invoices and payroll data, automates recurring work and keeps experts responsible for review and advice.

€18MSeries A
Participant
Intropy

AI-native platform automating inventory, pricing and other critical decisions for spare parts businesses

$11MSeed
Role not disclosed
Scape

Intelligent email inbox that prepares work proactively

$3.2MSeed
Role not disclosed
Neko Health

Neko Health provides body-scanning technology combined with bloodwork to assess health

$700MSeries C
Role not disclosed